India rejects Gilead\’s Hepatitis C drug patent request
As Gilead is the sole producer of sofosbuvir (no generic versions have been launched in any country), governments, MSF and other treatment providers are dependent on the willingness of the company to make this urgently-needed drug available and accessible.
India rejects Gilead\’s Hepatitis C drug patent request Read More »